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President-Sir WILLIAM WILLCOX, K.C.I.E., C.B., C.M.G., M.D., F.R.C.P.Lond. [May 14, 1940] DISCUSSION ON MODERN METHODS IN THE TREATMENT OF CEREBROSPINAL FEVER Dr. H. Stanley Banks: In 1937-38 , the method of treatment used at the Park Hospital (L.C.C.) was serum (meningococcus antitoxin) in massive dosage intravenously and sulphanilamide in high initial dosage by mouth. No serum was given intrathecally since it was known that the drug appeared rapidly in the cerebrospinal fluid in amounts sufficient to cause bacteriostasis. The serum was given in dosage of 100-150 c.c. on admission, and, in severe cases, was repeated on the following day. The dosage of the drug varied from 3 grm. daily (infants) to 9 grm. daily (adults) for three days, followed by gradual reduction. The period of administration averaged eight or nine days. The following table shows the age-grouping, bacteriological classification and case fatality of every case admitted during the period. These included two who died within a few hours of admission, one infant admitted in the chronic stage in fifth week of the disease, and one death from intercurrent ascending pyelitis. The table, therefore, represents the gross fatality rate of the series. The disease was, at this period, sporadic in incidence. The age-grouping in Table I is not dissimilar from that shown in Table II . Indeed it shows a smaller proportion in the unfavourable age-period under 5 years. Clinically, the cases were of roughly similar severity to those in the next sporadic period (rable II), yet the difference in the gross fatality rate was considerable. The dosage of the drug employed was similar in the two series, but, in the later series, approximately half the cases were treated with sulphapyridine. The statistical evidence, so far as it goes, shows no practical advantage gained from serum administration. I have already published some clinical evidence from the same series (Banks, 1939 ) that high intravenous dosage of serum does not compensate for low dosage of sulphanilamide. Accordingly, in spite of theoretical considerations, and experimental evidence (Brown, 1937; Branham and Rosenthal, 1937; Branham, 1940) , I am not at present convinced that serum administration is necessary or desirable, even as an adjuvant to chemotherapy. Table II shows the age-grouping and fatality rates of all cases received during the sporadic season 1938-39 and the epidemic period January 1 to April 30, 1940 . There are no exclusions whatever, and the fatality rates are gross. All these cases were treated with sulphanilamide or sulphapyridine, or both drugs combined in the dosage shown in Table VI , and, with a very few exceptions (mostly fatal cases), none had serum treatment. Gross fatality rate 6-25% 10% (no exclusions) The age-grouping is again thoroughly representative in both series. The highest agegroup fatality was 50% in infants under 1 year. This was associated with the high proportion of the " encephalitic " type met with especially in infants during the epidemic. The death-rate in the age-period over 40 years was remarkably low in the epidemic, one death only being recorded, a man of 74, who died of intercurrent hypostatic pneumonia.
The severe nature of the epidemic cases compared with the sporadic is reflected in Tables III and IV. In the epidemic, 41 % were assessed as " severe ", and 17% as " very severe ", while no less than 46% had a petechial or purpuric rash, some being covered with haemorrhages. Group I infections were present in 92% of 45 cases typed in the epidemic, as compared with 64% of 43 typed in the sporadic period. No less than 82% were admitted within three days of onset of meningeal symptoms in the epidemic as compared with 40% of the sporadic cases. 
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From Table IV , it is seen that no less than 20% of the epidemic cases were not bacteriologically verified. This is a measure of the rapidity of sterilization of the cerebrospinal fluid under chemotherapy, since a considerable number of cases had treatment before admission to the hospital. On clinical grounds, there could be no reasonable doubt as to the diagnosis. The same fact is brought out in another way in Table IV , which shows that in only 1 % was sterilization of the fluid delayed beyond forty-eight hours. 
1% 1%
Complications.-These were not serious apart from two cases of deafness, one absolute and one partial. In the epidemic series of 120 cases, there were 11 cases of polyarthritis, 2 of glycosuria with moderate ketosis, not accompanied by coma; 2 of multiple vesicles and ulcers formed in the purpuric areas throughout the skin surface; 1 of severe myocarditis with gallop rhythm, which subsided after three days; several cranial nerve palsies involving III, IV, VI, and VII; and Jacksonian convulsions in 6 recovered cases as well as in many of the fatal cases. The high proportion of arthritis cases was a striking feature. Some cleared up in a few days, others, particularly those in the knee-joint, showed fluid and synovial thickening for many weeks. At onset, the fluid had varying degrees of turbidity and did not yield the meningococcus on culture. The drug effects included 3 cases of haematuria which cleared up rapidly when sulphanilamide was substituted for sulphapyridine; 8 cases of drug rash and fever, which generally appeared about the eighth or ninth day of treatment, and 26 cases of persistent vomiting, all of which cleared up rapidly with change of drug from sulphapyridine to sulphanllamide. One case of granulocytopenia in a child was discovered on the day after drug treatment was stopped (ninth day). The white cell count, twenty-four hours later, reached its lowest level, 4,000 per c.mm. with 8 % polymorphs. Thereafter, it rose rapidly and recovery was rapid. In this case, pentnucleotide was given twice daily from the date of discovery of the condition.
It is of interest to compare the fatality rates in this and Dr. G. E. Harries' series with those in the provisional figures for the first quarter of 1940 supplied to me by the Ministry of Health. I am indebted to Dr. Percy Stocks, who has kindly compiled these figures at short notice, and to Sir Arthur MacNalty for permission to use them. Table V shows that, subject to adjustment which will probably involve about 30 deaths, there were, in England and Wales, during the period, 4,388 cases amongst civilians with a fatality rate of 23-7% and 705 cases among non-civilians with a fatality rate of 11-3%. The total cases involved were 5,093 with 1,120 deaths, a fatality rate of 22%. The age-group fatality rates shown in the table refer to 787 cases of which reports on treatment were received by the Ministry of Health. Treatment was by chemotherapy, either alone or in combination with serum.
The age-grouping shows a slightly lower proportion in the unfavourable age-periods under 1 year and over 45 years than is shown in my series, but, on the whole, it is not dissimilar. It is to be noted that the Ministry of Health's figures show a mortality of about 50% in each of the two age-periods under 1 year and over 45. These are obviously the ages of worst prognosis. It is worthy of note in passing that, while the case fatality rate for the country as a whole for the first quarter of the year has approximated to 22%, that of the two series reported to this meeting this afternoon aggregating 320 cases, does not amount to more than 10 or 11%. Table VI . The high dose shown for the initial period of two to three days has been used throughout in my cases, but the wvhole period of administration was latterly shortened to six to seven days instead of nine days. It is to be noted that the dose for infants and children is distinctly high as compared with adults, weight for weight, and should not be appreciably increased bv " loading" doses at the beginning of treatment. These should be omitted altogether at the lower ages in each dosage age-group. Loading dose (1st and 2nd): add i grm. below 5 years; add 4 grm. above 5 years. For very acute cases, it is desirable to give the first or first and second doses by intravenous injection of the sodium solution of sulphapyridine. In an adult, 1 grm. given intravenously will generally cause an immediate rise in the blood level of the drug which will settle in about two hours to approximately 2 mgm. per 100 c.c. higher than the blood level before the injection. Intramuscular injection of the sodium solution is, I think, at present, overdone. The tendency is to employ it whenever there is troublesome vomiting produced by the drug and when administration by mouth is difficult, as in the comatose and resistive. The better remedy for the first of these conditions is to change the drug to sulphanilamide. This has proved to be very effective in all 26 of my cases in which it was indicated and carried out. For the comatose and resistive, the technique of the cesophageal tube passed via nose or mouth should be mastered by doctors and nurses who treat those cases. By this means, not only can the drug be given effectively, but also the requisite fluids which are essential if dehydration is to be avoided. Intramuscular injection of the highly alkaline sodium solution causes necrosis of muscle fibres, and sloughs and ulcers if, as not infrequently happens, some of the solution enters the subcutaneous tissue. The following case, an early one in my series, illustrates the futility of repeated intramuscular injections, when there is persistent vomiting and dehydration S.B., aged 2)years, admitted third day of disease; profuse purpuric rash; repeated coffee grounds vomiting from admission until death thirty-six hours after admission. Drug administered by repeated irnjections of sodium solution intramuscularly. Cerebrospinal fluid content eighteen hours after treatment commenced was g-8 mgm.%. In spite of this high figure, the child died, wvith svmptoms of dehydration. Vomiting was persistent to the end, and, unfortunately, parenteral salines were not given.
Causes of death.-The main cause of death in my epidemic series was an acute encephalitis. The main brunt of the onslaught was borne by the brain itself and not the meninges in a certain very acute type of case which might be called the "encephalitic type". The syndrome is one of septicaemia, multiple haemorrhages, including profuse purpuric rash, and acute encephalitis, with no meningeal exudate. Clinically, there is profound coma and little rigidity. The duration of the illness from onset to death in five cases was fifteen to thirty hours. In two of these cases there was extensive adrenal haemorrhage, and, in these, the pulse was imperceptible from admission. The latter syndrome has been called in America the Waterhouse-Friderichsen syndrome (Clyde and Neely, 1939). Three of the cases were infants. The following is a typical example:-.A.H., aged 5 months, admitted eight hours after onset; complete coma; large hoemorrhages-tense pulsating fontanelle, not relieved by two lumbar punctures at three hours' interval. Died fifteen hours from onset. Post mortem, meningeal and ventri-cular exudate negligible. Brain tissue in sections showed great congestion and cedema, perivascular infiltration, widespread capillary hxmorrhages and thromboses, and extensive nerve-cell degeneration.
Somewhat less acute was the " encephalo-meningitic " type, the duration of the illness from onset to death being five to six days. Two varieties were encountered (a) that in which there was severe widespread acute encepharitis, and also some meningeal exudate in addition. This type was represented by a man, aged 22 years, who was completely comatose for three and a half days before he died, and who had also turbid cerebrospinal fluid, with meningococci, Group I. Post mortem, the meningeal exudate was minimal, and brain sections showed similar appearances to those described above, but with more marked perivascular infiltration, (b) the second variety was represented by three infants, all of whom had slight acute encephalitis, but profuse thick purulent exudate all over the veitex of the brain. The outstanding clinical manifestations in this type were repeated convulsions and deep coma. The other causes of death wvere well-recognized types:
(1) Hydrocephalus from subarachnoid block in an infant admitted in the third week of the disease; (2) toxaemia with dehydration from excessive vomiting; and (3) intercurrent hypostatic pneumonia in an elderlv subject.
Conclusions as to treatment.-(i) At present two drugs should be used and each has its indications.
Sulphapyridine by mouth is first choice, but, if it causes vomiting twice, nausea, depression or haematuria, it should not be used further, nor should the sodium solution be injected as is the present common practice. These symptoms are clear indications for the change of drug to sulphanilamide, and this change may be needed in about a quarter of the cases. As sulphanilamide is less potent than sulphapyridine, the dosage must be adequate (9 grm. daily for an adult in the initial period of two to three days and gradually reduced). There is some recent evidence, both experimental and clinical, that a third drug, sulphathiazole is about as potent against meningococci as sulphapyridine and is less liable to cause vomiting. This may yet be the drug of choice.
(2) The dosage scale recommended is designed for sulphanilamide; it is somewhat high for sulphapyridine but appears to be safe if not exceeded. The scale dosage is considerably higher for children than for adults, weight for weight. Consequentlv, in children, it should never be exceeded, and any increment in the first two " loading doses'" should not exceed I/4 grm. No loading dose is necessary at the lower ages in each dosage age-group.
(3) The period of administration in the average case should not exceed six to seven days. Drug rash and fever, although relatively harmless, become a definite risk about the eighth or ninth day of treatment. Granulocytopenia is a rare risk, but probably depends largely upon idiosyncrasy.
(4) Intravenous sodium solution of sulphapyridine in two initial doses each of 2 grm. for an adult, diluted in three volumes of saline is recommended for very acute cases, and, in suitable dosage, where the drug cannot be given by mouth or catheter. The concentration of the drug in the cerebrospinal fluid some two hours after intravenous injection of 1 grm. settles to a level of about 2 mgm. / higher than that before the injection. There is, however, no need for injections in the average moderately severe or mild case.
(5) Intramuscular injection of the sodium solution causes necrosis of muscle fibres, and extensive sloughs and ulcers if there is any spilling into subcutaneous tissues. It should only be used when there is no other alternative, and then as sparingly as possible.
(6) Spinal drainage for two or three days is still required in a small proportion of cases to relieve pressure symptoms. Examples of such symptoms are : Slow pulse ; slow respirations; headache; restlessness; tense fontanelle.
(7) Fluid administration especially to small children is of major importance in order to prevent or relieve dehydration. The technique of the nasal and pharyngeal tube should be mastered. In dehydration, delay in giving parenteral fluid may be fatal. The intraperitoneal route is often convenient and should be more widely used. Vomiting should be treated by change of drug.
(8) Variations in case fatality rates should now mainly depend upon (a) the proportion of acute cases of the encephalitic or encephalo-meningitic types in any series, (b) the proportion of subjects over 40 years of age with severe intercurrent disease. Case fatality rates over 15% in a mixed series should be viewed with suspicion if they cannot be explained on the above basis.
(9) Acute coma accompanied by a purpuric rash may indicate the rapidly fatal encephalitic type and should, therefore, be an indication for immediate treatment with sulphapyridine pending admission to hospital.
(10) Drug treatment acts more rapidly than serum. Although combined serum and drug treatment has theoretical and experimental sanctions, I have been unable to obtain any practical evidence of the value of serum as an adjuvant. Dr. G. Emrys Harries: Since the beginning of this year over two hundred cases of cerebrospinal fever have been admitted to the City Isolation Hospital, Cardiff. The following is a brief re'sume of the treatment of these first two hundred cases
The ages ranged from io weeks to 70 years. Females 93.
All except 18 were civilian cases. There were 22 deaths, giving a case mortality of 11%. There was no death in the 18 non-civilian cases which had been diagnosed early. If six cases that died within six hours of admission, together with another four cases admitted moribund on the fourth day of disease or after, be excluded, the case mortality would be reduced to approximately 6%.
One case was a purely meningococcal septicaemia, cerebrospinal fluid being normal, and no changes apart from meningeal congestion found in the nervous system post mortem. A few cubic centimetres of blood taken during life, however, and haemolysed with dilute acetic acid showed gram-negative diplococci in the centrifuged deposit. The cases generally have been more severe than in sporadic cases in previous years, and were particularly so during the height of the epidemic. In only two instances was more than one case admitted from the same household.
Petechial haemorrhages were present in 41% of cases, herpes in 25-5%, and petechia and herpes present in 13-0% cases. One case with extensive vibices up to the size of a penny made a complete recovery. 93 strains of meningococci were isolated in culture from the cerebrospinal fluids. Of these, 90 belong to Group I, 2 showed no agglutination, and 1 strain showed autoagglutination, and could not be grouped. In 75 cases morphological meningococci were found in direct smears from deposits, but failed to grow on culture. Some of these patients had already had M & B 693 prior to samples of cerebrospinal fluid being taken. In 32 cases mostly following treatment with M & B 693 meningococci were not seen in stained smears of deposits, and also failed to grow on culture.
Complications.-Bronchopneumonia (was the chief cause of death in 6 cases). 38 transient albuminuria; 4 hydrocephalus; 3 iridocyclitis; 4 bilateral nerve deafness; 1 orchitis 3 adrenal haemorrhages (verified post mortem); 10 arthritis (one prior to admission); 1 right transient hemiplegia; 1 transient paresis of forearms; 2 mental derangement persisted for two months; 38 transient strabismus.
Treatment. Four tablets (i.e. 2 grm.) M & B 693 by mouth on admission, repeated in four hours' time, and then two tablets four-hourly for seventy-two hours. Then, provided the sugar content of the cerebrospinal fluid was approaching normality, the dosage was reduced to one tablet six-hourly for twenty-four hours, and then one tablet t.d.s. for a further three or four days. Children under 12 years received half the adult dosage, irrespective of the age of the child, as even infants appear to tolerate the drug quite well. Lumbar punctures were performed daily until the sugar content of the cerebrospinal fluid was satisfactory, and no case of meningitis was considered out of danger if the sugar had not returned. Only in a few instances were cisternal or ventricular punctures considered necessary. If the patient was comatose, the tablets were crushed and given in nasal feeds. If vomiting occurred after ingestion of M & B 693, or the patient was delirious and nasal feeding was difficult, the sodium salt of M & B 693 in equivalent doses was given by intramuscular injections. In severe cases the sodium salt of M & B 693 was given intravenously in about %/2 to I litre of normal saline, in 5 % glucose solution, by the Vacoliter drip method. It was generally unnecessary to cut down on a vein for this purpose. No serum was given intrathecally, but 30 to 60 c.c. meningococcal antitoxin were given intravenously in the normal saline in severe cases. Fluids were pushed in all cases, as to my mind dehydration can contribute materially towards the fatal issue, and three patients who ultimately recovered after being in coma for five, seven and ten days respectively had been given fluids by nasal feeds at four-hourly intervals. All patients were given glucose freely, and even in the mild purpuric cases a little sodium chloride was added to the fluid diet.
Since extensive haemorrhages are not infrequently found in the adrenals, cortical extract was given in the fulminating cases intramuscularly, and salines, as already indicated, were given intravenously in the severe haemorrhagic cases, as according to McCance in the Goulstonian lectures of 1936 sodium chloride is advocated in cases of adrenal damage. Three patients whose pulses were imperceptible on admission made complete recoveries when treated on these lines. In passing, I may mention that in haemorrhagic cases where bromides were given as sedatives, sodium bromide was administered in lieu of potassium bromide.
The sulphapyridine reactions were not alarming. 16 developed sulphonamide skin eruptions; 1 jaundice; 6 marked cyanosis; 2 transient haematuria; 2 ulcerations.
No case developed agranulocytosis. No person in attendance on these cases contracted the disease. No masks were worn, as the wearing of masks I believe predisposes to nasopharyngeal congestion and catarrh, which probably lowers the resistance of the mucous membranes.
In conclusion, I should like to give a word of warning regarding the giving of small doses of M & B 693 as a prophylactic in suspected cases. Small doses appear to be without effect on the meningococci, and what is more, the organisms are rendered drugfast, and large doses administered later are then less effective.
Dr. Allison of the Ministry of Health Emergency Laboratory Service kindly arranged for the typing of the organisms, and Dr. Boissard carried out the post-mortem examinations.
Dr. W. R. Thrower, speaking in place of Dr. Whitelaw, gave an account of some of the recent work carried out on the clinical pathology of sulphonamide therapy, with particular reference to the treatment of meningitis with M & B 693. He gave a resume of certain aspects of the problem which were of general interest and laid particular stress on the factors operating in parenteral therapy owing to the fact that sulphonamides as a class were sparingly soluble in water, which limited their use in the natural state, while the attachment of a solubilizing group often materially reduced their activity. The soluble sodium salts of some compounds, particularlv M & B 693, retained their therapeutic activity and thus justified their use in clinical medicine, but the high alkalinity necessitated care in the manner of administration. While the intravenous use of M & B 693 soluble would appear to be the route of choice, considered opinion was that the complete barring of intramuscular medication might prevent acutely ill cases obtaining the benefit of a soluble preparation, were no suitable veins available or were the practitioner unwilling to undertake the procedure.
The direct effect of M & B 693 soluble upon muscle had been studied in various animals JULY-THERAP. 2 and histological preparations made at different times after injections. The muscle fibres stained poorly, lost their striation, and became separated from one another by tissue exudate. After a time resolution of the changes occurred, but this somewhat surprising tolerance depended upon active circulation in the muscle, as also did the level of the drug in the blood. If the circulation in the muscle at the site of injection was sluggish, as was frequently the case in collapsed or severely ill patients, the position was different as the compound remained partly localized and was inadequately absorbed, and local necrosis could occur. In these cases with peripheral circulatory stasis only intravenous medication was likely to be effective.
The levels of sulphanilamide in the blood-stream and cerebrospinal fluid were commonly the same; with M & B 693, however, the position was different, as the levels in the cerebrospinal fluid were usually 60% of those in the general circulation, but at times only faint traces of the compound could be identified in the spinal fluid, despite adequate intake and good blood levels.
Post mo'rtem it had been demonstrated that the cases which in life showed only a trace of M & B 693 in the cerebrospinal fluid had extensive choroidal derangement through inflammatory changes. The fact that these varying levels occurred with M & B 693 whereas the sulphanilamide content ran parallel with that in the blood-stream suggested that the former compound was actively secreted by the choroid. A further point was that shortly before death, when the secretory mechanism failed and pure filtration came into action, the levels in the cerebrospinal fluid and blood-stream approximated.
The optimum effective level of M & B 693 against meningococci in the cerebrospinal fluid had not yet been determined, but it was interesting to note what small traces could be active. Traces too small to be measured quantitatively would materially affect the investigation of apparently highly infected fluids, since growth of meningococci might not be obtained until after forty-eight hours' incubation, and this gave a warning against the too ready acceptance of negative culture reports on fluids withdrawn once treatment had commenced.
Dr. Mervyn Gordon pointed out that, as in 1915, the present outbreak was due to the chief epidemic strain of the meningococcus, Type I. At the height of the 1915 outbreak as many as 120 cases occurred weekly among recruits, and the mortality was 50%. This mortality continued until the late Martin Flack by clinical trial found-a batch of serum that reduced the mortality in his district to 18-5% while it still rermained at 50% in other districts. The potency of this serum was due to its anti-endotixic capacity, and ultimately, with considerable difficulty, serum was prepared that reduced the death-rate in Type I cases, though not in others, to 10%/.
He expressed his admiration of the recent advances by means of chemotherapy, and especially of the work of Dr. Stanley Banks who had obtained such a striking reduction in the mortality of cases due to other types as well as Type I. There was, however, at present too great a difference in the mortality rate of cases treated by experts and by others, and he quoted an instance of an outbreak in a remote village where there had been five cases and five deaths, the disease being mistaken for influenza. Special machinery was needed to diffuse this new knowledge to the profession generally, and to secure its early and successful application. This seemed to be a matter for the Ministrv of Health, or the Medical Research Council.
